您好!很高兴为您提供一对一的专属咨询。
请问有什么可以帮您?
冻卵的流程和价位是什么?

Anti-Müllerian Hormone (AMH) level is a "barometer" for measuring a woman's ovarian reserve function. For women with low AMH, the fertility window may be shorter than expected. Facing fertility uncertainty, understanding the relationship between AMH and ovarian health, and planning for US and Mexico egg freezing or IVF-PGT strategies, is crucial for guaranteeing future pregnancy preparation success.
Over the past decade, the importance of AMH as a biomarker for reproductive health has been consistently recognized by the medical community.
International Medical Consensus: Both the American Society for Reproductive Medicine (ASRM) and the American College of Obstetricians and Gynecologists (ACOG) emphasize that AMH is the most reliable marker for assessing ovarian reserve and predicting IVF treatment outcomes.
Advantage of Cycle Stability: Although many reproductive hormones fluctuate during the menstrual cycle, AMH is relatively stable throughout the entire cycle, fluctuating less than other hormones, and can more accurately reflect the true ovarian reserve status.
The medical community agrees that women with diminished ovarian reserve have a shorter reproductive lifespan and an earlier age of menopause. As society generally delays childbearing, understanding AMH levels is essential for pregnancy preparation planning.
Sign of Declining Fertility: When the AMH level is below $1.3 ext{ ng/mL}$ (defined as "slightly low"), it is often associated with lower success rates in IVF or egg freezing. If a young woman presents with low AMH, this is a clear indication of reduced ovarian reserve.
Tracking the Rate of Decline: Regularly tracking AMH level changes helps monitor the rate of ovarian reserve decline. In extreme cases, very low AMH, missed periods, and perimenopausal symptoms may be markers of Primary Ovarian Insufficiency, which can lead to a long-term or permanent cessation of the menstrual cycle before age 40.
For women facing fertility pressure due to low AMH levels, especially single women constrained by domestic policies, overseas assisted reproduction offers a solution.
Egg Freezing for Single Women: Domestic policies do not allow medical institutions to provide assisted reproductive services to unmarried single women. Overseas services like US and Mexico egg freezing offer single women a legal and safe path to preserve high-quality eggs, avoiding missing the optimal time for conception.
For families who ultimately choose IVF, especially women with poor ovarian reserve function, IVF-PGT technology is a powerful tool to maximize the assurance of the child's health.
PGT Screening Advantage: By performing chromosomal and major genetic disease screening (PGT) on frozen embryos, abnormal embryos can be accurately excluded, significantly increasing the implantation success rate and live birth rate, ensuring the health of the future child.

Understanding one's AMH level and ovarian reserve status is the first step for all pregnancy preparation families. Whether it requires US and Mexico egg freezing to lock in fertility or using IVF-PGT technology to optimize embryo quality, professional guidance is indispensable.
The IVF USA team, founded by Dr. Nathan Zhang, has been providing overseas assisted reproductive consulting services for over a decade, offering US egg freezing, US IVF, and third-party assisted reproductive services to those in need. With nearly 20 years of deep expertise in the overseas assisted reproductive field, IVF USA, driven by diverse and personalized reproductive needs, strategically expanded into the Mexican market early on, becoming the authorized agent for Power Fertility Center Mexico (POWER IVF) in China. Dr. Nathan Zhang's services currently extend beyond the US to include IVF and egg freezing in Mexico, Japan, and Thailand, as well as Taiwan and Hong Kong. We will help you move toward the happiness of having a healthy baby.